Defymed's mission is to develop innovative medical devices for diabetic patients providing effective treatments and improving quality of life
million diabetics worldwide forecasted for 2045
billion per year spent on diabetes-related expenses
more than 10
million diabetics receiving insulin therapy have poorly regulated blood glucose levels
June 15 2018
Strasbourg, June 26-27th 2018: We are happy to announce that Defymed won the “Start-up Slams” and i...
May 31 2018
Paris, June 6th 2018: We are very happy to participate for the second time to this innovative start-...